# Enoxaparin Versus Unfractionated Heparin in PCI

> **NCT00439855** · PHASE4 · COMPLETED · sponsor: **Triemli Hospital** · enrollment: 2100 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Enoxaparin i.v.
- **DRUG:** unfractionated heparin

## Key facts

- **NCT ID:** NCT00439855
- **Lead sponsor:** Triemli Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 2100 (—)
- **Last updated:** 2007-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439855, "Enoxaparin Versus Unfractionated Heparin in PCI". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT00439855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*